Please assess the completion status of the following clinical trial:

Trial Title: Continuous Infusion of Local Anesthetic for Optimal Post Operative Pain Control Following Hemorrhoidectomy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients scheduled for hemorrhoidectomies at NMCP~Exclusion Criteria:~* Any patient with co-existing active purulent infection (i.e. abscess).~* Any patient who has had previous surgical intervention for his/her hemorrhoidal disease. Previous simple incision to treat a thrombosed hemorrhoid is not considered a surgical intervention for the purposes of this study. The minimal scar produced by a small incision would not alter post-operative pain following removal of a hemorrhoidal column.~* Any patient allergic to local anesthetics or oral pain medications~* Any patient with a history of chronic pain~* Any patient allergic to or has had an adverse reaction (i.e. history of gastrointestinal bleed) to a non-steroidal anti-inflammatory drugs (NSAIDs)~* Any patient pregnant patient

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 99 Years
- Healthy Volunteers: t

Study Arms:
- Pump device (Type: PLACEBO_COMPARATOR): One arm will have continuous subcutaneous infusion of normal saline.
- Bupivacaine (Type: ACTIVE_COMPARATOR): will receive continuous infusion of bupivacaine

Based on this trial design, predict the completion outcome and termination type (if applicable).